# EDGAR Filing Document

**Accession Number:** 0001787792
**File Stem:** 0001787792-26-000006
**Filing Date:** 2026-4
**Character Count:** 2958
**Document Hash:** 1fb5d496b28a3e3895f79c813c55565c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001787792-26-000006.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001787792-26-000006

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fisher Wallace Laboratories, Inc.
- **CENTRAL INDEX KEY:** 0001787792
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 208131183
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-25712
- **FILM NUMBER:** 26920759

**BUSINESS ADDRESS:**
- **STREET 1:** 515 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 917-930-4332

**MAIL ADDRESS:**
- **STREET 1:** 630 FLUSHING AVENUE, BOX 104
- **CITY:** BROOKLYN
- **STATE:** NY
- **ZIP:** 11206

### Attached PDF Documents

**Attachment 1:** `fwlformcar25.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Fisher Wallace Laboratories, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 08-23-2019

**Physical Address:** 630 FLUSHING AVENUE, BOX 104, BROOKLYN, NY, 11206

**Issuer Website:** fisherwallace.com

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 3.00

**Total Assets (Most Recent Fiscal Year):** $144,634.00

**Total Assets (Prior Fiscal Year):** $154,382.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $48,142.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $41,626.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $591,311.00

**Short-Term Debt (Prior Fiscal Year):** $596,721.00

**Long-Term Debt (Most Recent Fiscal Year):** $693,612.00

**Long-Term Debt (Prior Fiscal Year):** $925,582.00

**Revenues/Sales (Most Recent Fiscal Year):** $34,261.00

**Revenues/Sales (Prior Fiscal Year):** $47,412.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $5,049.00

**Cost of Goods Sold (Prior Fiscal Year):** $3,012.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-1,447,538.00

**Net Income (Prior Fiscal Year):** $-1,579,900.00

### Signatures

**Issuer:** Fisher Wallace Laboratories, Inc.

**Signature:** /Kelly Roman/

**Title:** Chief Executive Officer and Director

---

**Signature:** /Kelly Roman/

**Title:** Chief Executive Officer and Director

**Date:** 04-30-2026